mhra
MHRA expands application information for London regulatory sandbox
MHRA has added information on the next application stage for its London sandbox, including what happens after expressions of interest have been screened.

What Changed
The Medicines and Healthcare products Regulatory Agency (MHRA) revised its London Region I MHRA Regulatory Sandbox call for expressions of interest on 18 November 2026. The guidance now includes information on the next application stage, including what happens after expressions of interest have been screened.
The call concerns participation in an initiative exploring the safe and responsible deployment of innovative technologies in real-world healthcare settings in London.
Who Is Affected
The invitation is directed at AI-enabled medical device manufacturers and NHS provider organisations interested in participating. The sandbox will bring together manufacturers, NHS organisations and regulatory experts.
Separate expression-of-interest forms are available for manufacturers and providers.
Regulatory and Technical Implications
The sandbox’s stated focus is safe and responsible deployment in healthcare practice. MHRA describes a collaborative setting involving technology developers, healthcare organisations and regulatory expertise.
The 18 November revision concerns the application pathway. The publication’s change record identifies post-screening information as the addition; applicants should consult the HTML guidance for the detailed next-stage arrangements.
Manufacturer Actions
Interested manufacturers can consult the HTML guidance and the manufacturer expression-of-interest form. The manufacturer form is listed as an 84.3 KB Word document, while the provider form is 82.5 KB.
MHRA warns that these files may not be suitable for assistive-technology users. Accessible versions can be requested at webupdates@mhra.gov.uk, specifying the required format and, where possible, the assistive technology used.
Confirmed Dates
The sandbox was announced in June 2026. The call was first published on 30 July 2026, and the next-stage application information was added on 18 November 2026.
The publication page does not specify an application deadline.
Official Source
MHRA’s GOV.UK publication, “London Region I MHRA Regulatory Sandbox: call for expressions of interest”, contains the HTML guidance and both expression-of-interest forms.
Https://www.gov.uk/government/publications/london-region-i-mhra-regulatory-sandbox-call-for-expressions-of-interest
Source and related services
Guidance: London Region I MHRA Regulatory Sandbox: call for expressions of interest ↗Source date: 18/11/2026
This news provides general information and does not replace device-specific legal or conformity assessment advice.